Molecular farming can be defined as the use of plants to produce recombinant protein
products. The technology is now> 30 years old. The early promise of molecular farming was …

Herbal remedies were the first medicines used by humans due to the many
pharmacologically active secondary metabolites produced by plants. Some of these …

Plant molecular farming (PMF), defined as the practice of using plants to produce human
therapeutic proteins, has received worldwide interest. PMF has grown and advanced …

Plant cell culture systems were initially explored for use in commercial synthesis of several
high‐value secondary metabolites, allowing for sustainable production that was not limited …

Plants have unique advantages over other systems such as mammalian cells for the
production of valuable small molecules and proteins. The benefits cited most often include …

Plants have emerged as commercially relevant production systems for pharmaceutical and
nonpharmaceutical products. Currently, the commercially available nonpharmaceutical …

The market for biopharmaceuticals is dominated by recombinant proteins and is driven
mainly by the development of vaccines and antibodies. Manufacturing predominantly relies …

Plants offer the tantalizing prospect of low-cost automated manufacturing processes for
biopharmaceutical proteins, but several challenges must be addressed before such goals …

The purification of recombinant proteins by affinity chromatography is one of the most
efficient strategies due to the high recovery yields and purity achieved. However, this is …

Many different plant-based systems have been used to produce recombinant
pharmaceutical proteins but only a small number have made the leap from an experimental …